Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 6/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | PLAU | P00749 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.40 |
| ▸ | MAOA | P21397 | 2/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1199563 | 1.00 | EPHX1 (0.52) | EPHX1TSHRPLAUCHRM2CHRM4 | |
| SCHEMBL63809 | 1.00 | EPHX1 (0.52) | EPHX1TSHRPLAUCHRM2CHRM4 | |
| SCHEMBL270441 | 1.00 | EPHX1 (0.52) | EPHX1TSHRPLAUCHRM2CHRM4 | |
| SCHEMBL1199046 | 1.00 | EPHX1 (0.52) | EPHX1TSHRPLAUCHRM2CHRM4 | |
| SCHEMBL12914371 | 1.00 | EPHX1 (0.52) | EPHX1TSHRPLAUCHRM2CHRM4 | |
| SCHEMBL3644410 | 1.00 | EPHX1 (0.52) | EPHX1TSHRPLAUCHRM2CHRM4 | |
| SCHEMBL6570141 | 0.97 | EPHX1 (0.50) | EPHX1TSHRPLAUCHRM2CHRM4 | |
| SCHEMBL4279301 | 0.97 | EPHX1 (0.50) | EPHX1TSHRPLAUCHRM2CHRM4 | |
| Lithium SCHEMBL29397282 | 0.97 | EPHX1 (0.50) | EPHX1TSHRPLAUCHRM2CHRM4 | |
| Methyl Alcohol SCHEMBL8767938 | 0.91 | EPHX1 (0.46) | EPHX1TSHRPLAUCHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10774060-B2 | Oxone-aceton mediated metal free preparation of syn-diols | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2020-09-15 | — | — | US | disclosed |
| US-20160168114-A1 | Oxone-Aceton Mediated Metal Free Preparation of Syn-Diols | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-06-16 | — | — | US | disclosed |
| US-8153551-B2 | Optical isomer separating filler | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-10 | — | — | US | disclosed |
| US-20100041878-A1 | Optical Isomer separating filler | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-02-18 | — | — | US | disclosed |
| US-20080132695-A1 | Cross-linked Polysaccharide Derivatives | FRANCOTTE ERIC | 2008-06-05 | — | — | US | disclosed |
| US-20080132695-A1 | Cross-linked Polysaccharide Derivatives | FRANCOTTE ERIC | 2008-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168114-A1 | Oxone-Aceton Mediated Metal Free Preparation of Syn-Diols | SQLE, OXER1, OXA1L | EPHX1 964/4885TSHR 4730/4885PLAU 4470/4885 |
| US-10774060-B2 | Oxone-aceton mediated metal free preparation of syn-diols | SQLE, OXER1, OXA1L | EPHX1 964/4885TSHR 4730/4885PLAU 4470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.